NovoCure NVCR Deferred Tax Assets and Other Non-Current Assets
Deferred Tax Assets and Other Non-Current Assets at other companies
Other financials
Where this comes from
Reported directly by NovoCure in its filing.
Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.
The official record: NovoCure’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about NovoCure's deferred tax assets and other non-current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is NovoCure's deferred tax assets and other non-current assets?
- NovoCure (NVCR) reported deferred tax assets and other non-current assets of $11.2M in Q1 2026.
- How has NovoCure's deferred tax assets and other non-current assets changed year-over-year?
- NovoCure's deferred tax assets and other non-current assets decreased by 22.7% year-over-year, from $14.48M to $11.2M.
- What is the long-term trend for NovoCure's deferred tax assets and other non-current assets?
- Over 5 years (2020 to 2025), NovoCure's deferred tax assets and other non-current assets has grown at a -0.6% compound annual growth rate (CAGR), from $10.91M to $10.6M.